Nuvation Bio to advance glioma drug to Phase III trial after positive three-year data
Nuvation will launch two new studies of safusidenib in glioma, a global pivotal trial and a Phase II trial in the US.
Therapy Area
Inflammasome sets sights on Phase III amid eye disease drug’s mid-stage score
Takeda unveils secondary endpoint data from Phase III PsO pill trials
Veradermics stock jumps again on female hair loss drug win
Loneliness interventions do not have strong sustained effects on memory function
AAIC26: Biogen stock drops after unveiling tau-targeting ASO data
Alkermes releases nine-month data as OX2R race heats up
Roche culls development of two Huntington’s disease programmes
